ClinicalTrials.Veeva

Menu

Effects of Analgesia Nociception Index (ANI)-Guided Analgesia on Postoperative Bowel Function.

Y

Yonsei University Health System (YUHS)

Status

Enrolling

Conditions

Postoperative Bowel Function Recovery

Treatments

Other: Control
Device: ANI

Study type

Interventional

Funder types

Other

Identifiers

NCT05122078
3-2021-0348

Details and patient eligibility

About

Investigators will examaine the effects of Analgesia Nociception Index (ANI)-guided analgesia on postoperative bowel function recovery in laparoscopic colorectal surgery. This is a prospective randomized-controlled study.

Investigators will randomly divide the patients into two groups. In ANI group, remifentanil infusion rate during anesthesia will be adjusted according to ANI monitoring. In Control group, remifentanil infusion rate during anesthesia will be adjusted according to the conventional method of blood pressure and heart rate monitroing. And Investigators will evalualte the bowel function recovery in both groups after surgery, and compare between the two groups.

Enrollment

80 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients over 19 years who undergo laparoscopic colorectal surgery for colorectal cancer at Gangnam Severance Hospital, Seoul, South Korea.

Exclusion criteria

  • Emergency surgery
  • Patients with history of open abdominal surgery
  • Patients with arrhythmia
  • Patients with pacemaker insertion
  • Patients with history of heart transplantation
  • Patients taking medications that may affect ANI (antimuscarinics, alpha-agonists, beta blockers)
  • Patients with chronic opioid medication.
  • Cognitive impairment
  • Unable to read consent form (eg illiterate, foreigner, etc.)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

ANI group
Experimental group
Description:
Investigator will attach the ANI monitor V2 (MDoloris Medical Systems, Lille, France) to the patient and monitor Analgesia Nociception Index (ANI) during anesthesia. Remifentanil infusion rate is adjusted according to ANI monitoring. The ANI is adjusted to be between 50 and 70.
Treatment:
Device: ANI
Other: Control
Control group
No Intervention group
Description:
Remifentanil infusion rate is adjusted according to the conventional method of blood pressure and heart rate monitroing. Blood pressure and heart rate are controlled to be within 20% of baseline. We will not monitor ANI in this group.

Trial contacts and locations

1

Loading...

Central trial contact

Myung IL Bae; Young Song

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems